The TDF Awards

These grants provide up to $50,000 to advance early-stage technologies in the validation or proof-of-concept phase. The award is intended to add value to the technology and increase the probability of licensing.

  • Prototype development
  • Biological target validation and screening
  • Animal model development
  • Other advanced pre-commercial research

These grants provide up to $150,000 to advance later-stage technologies whose concept has been proven. Like the pilot grant, this award is intended to add value to the technology and increase the probability of licensing to an established company or startup. Development grants can be used for:

  • Prototype development
  • Human clinical studies
  • Pre-clinical data packaging
  • Drug delivery development
  • Large animal studies
  • Other advanced pre-commercial research.


*Note: Awarded projects must be completed within 12-18 months from the initial payment. A minimum of 70 percent of the project must be performed by a contract research organization (CRO) – this includes the internal ARCH facilities.


Info Session

Item Date
Proposals Due April 15 by EOD (5pm EDT)
Feedback May
Presentation Slides Due June
Advisory Board Presentation June/July
Award Announcement August


For additional information, please refer to our 2022 TDF Policies and Guidelines or contact us at technology.development@childrens.harvard.edu.